Biotech firm Synaptogenix has made an unexpected move into the crypto space, revealing its first acquisition of Bittensor (TAO) as part of a broader treasury diversification strategy.
The company confirmed the purchase in an official statement, marking a shift in focus toward digital assets, with a particular emphasis on crypto projects tied to artificial intelligence. Though the exact size of the TAO investment remains undisclosed, Synaptogenix previously hinted it could allocate up to $10 million toward the asset.
To manage its new crypto position, Synaptogenix has partnered with BitGo, which will handle custody, trading, and staking services. CEO Joshua Silverman credited strategy advisor James Altucher for steering the firm toward TAO, calling it a long-term bet on both income generation and AI-driven blockchain innovation.
“Our alliance with BitGo and the choice to invest in TAO reflect our belief in the asset’s potential to deliver value over time,” Silverman said, positioning the move as a step toward long-term shareholder growth.
As institutional players build exposure to familiar names like Bitcoin and Ethereum, Synaptogenix’s pivot toward TAO places it among the early adopters of next-generation AI-integrated crypto assets.
Ethereum (ETH) is showing renewed strength as it climbs to $3,418.86, posting a 21.33% gain over the past week.
Ethereum has taken center stage in crypto discussions, overtaking Bitcoin in retail FOMO (fear of missing out) just days after BTC’s record-setting rally.
Ethereum has reclaimed the spotlight, surging past $3,285 for the first time since January amid a powerful rebound in both price and network engagement.
Pudgy Penguins (PENGU) just pulled off something spectacular – shooting up 124% in seven days to hit $0.033. PENGU now boasts a market cap of over $2.1 billion, plus it has overtaken DOGE to become the most traded meme coin globally. But while PENGU’s having its moment, there’s a newer token – Snorter – which […]